Diabetes Drug

WASHINGTON (AP) -- The makers of the diabetes drug Avandia are disputing the federal government's claims the drug is linked to an increased risk of heart attacks.

A doctor with the Food and Drug Administration today recommended to a daylong conference of experts that Avandia be pulled from the market.

However, officials at GlaxoSmithKline cite their own analyses of studies, calling the data inconsistent. They say the research offers no overall evidence of differences with other antidiabetes drugs when it comes to heart risks.

They're scheduled to spell out their position to the meeting in Washington later today.

You must be logged in to post comments.

Password (case sensitive):
Remember Me:
23 WIFR 2523 North Meridian Road Rockford, IL. 61101 Business: 815-987-5300 Fax: 815-965-0981 News: 815-987-5330 Fax: 815-987-5333
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 8808847 - wifr.com/a?a=8808847
Gray Television, Inc.